Hospital Mortality in Acute Decompensation of Alcoholic Liver Cirrhosis: Can Novel Survival Markers Outperform Traditional Ones?

Božidar Dejanović, Otto Barak, Petar Čolović, Nebojša Janjić, Željka Savić, Nikola Gvozdanović, Maja Ružić

Abstract read

In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

Monocyte-to-Platelet Ratio Shows Modestly Improved Discrimination Over Model for End-Stage Liver Disease (MELD) 3.0 in Predicting 1-Year Mortality in Patients With Chronic Liver Failure and Hepatic Encephalopathy.Cureus · 2026
Article
Prediction of hospital length of stay in decompensated cirrhosis using hematologic and inflammatory indices.American journal of translational research · 2026
Article
miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease-A New Diagnostic Path?Biomedicines · 2025
Article
Differential impact of neutrophil-to-lymphocyte ratio and time-weighted NLR on mortality and survival in critically ill children: insights from a retrospective study.Frontiers in pediatrics · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Božidar DejanovićFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-1315-6499

Otto BarakFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0001-6727-8304

Petar ČolovićDepartment of Psychology, Faculty of Philosophy, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0003-1212-3131

Nebojša JanjićFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-1017-9978

Željka SavićFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0003-0720-4738

Nikola GvozdanovićFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

Maja RužićFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0003-1820-9067

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ALCalcoholic liver cirrhosisFIB4hospital mortalityNLR

Identifiers

PMID39458158

DOI10.3390/jcm13206208

PMCPMC11508931

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.